Background {#Sec1}
==========

Due to an ageing population, multimorbidity (two or more long-term conditions existing in one individual \[[@CR1]\]) is increasing \[[@CR2]\]. Studies have shown that the prevalence of multimorbidity in the elderly (≥ 65 years) is greater than 60%, and more than half of people with multimorbidity have three or more long term conditions \[[@CR3]\]. Patients with multimorbidity experience higher disease burden than patients with single conditions and are at increased risk of high treatment burden- the effort required of patients to look after their health and the impact this has on their general wellbeing (e.g. attending multiple appointments with different health professionals, taking medicines at different times in the day) \[[@CR4], [@CR5]\]. Studies have shown that high treatment burden is associated with reduced quality of life and adherence to treatment \[[@CR6], [@CR7]\], high hospitalization rates and high mortality \[[@CR8]\].

There is a lack of research investigating treatment burden-for-patients with multimorbidity in China. Having a validated measure of treatment burden is essential to improving understanding of factors associated with high and low treatment burden, and to testing interventions that aim to reduce treatment burden. There is one existing generic measure of treatment burden that has been translated into Chinese, known as the Chinese Treatment Burden Questionnaire (C-TBQ). This measure was validated in a younger study population (median age 62 years). It is also a longer questionnaire to complete with 15 questions.

The multimorbidity treatment burden questionnaire (MTBQ) was developed and validated in the UK to assess treatment burden for patients with multimorbidity. Based on the treatment burden framework developed by Eton et al. \[[@CR4]\] in 2012, the MTBQ is short, simple, and easy to use \[[@CR9]\]. It was validated in over 1500 older patients (mean age 71 years) with multimorbidity (≥ 3 long term conditions) and demonstrated good content validity, construct validity, reliability and responsiveness. The MTBQ has been translated into Danish and used in a population health survey, in which it showed good reliability and validity \[[@CR10]\].

The purpose of this study was to translate and culturally adapt the MTBQ into Chinese and to test the psychometric properties of the questionnaire among Chinese-speaking elderly patients with multimorbidity in hospital.

Method {#Sec2}
======

Participants {#Sec3}
------------

The data was collected from one hospital in Zhengzhou City, Henan province, China between August and October 2019. Patients were invited to take part if they met the following inclusion criteria: (1) complete hospital records and diagnosis at time of discharge; (2) two or more long term conditions; (3) age ≥ 60 years. Patients were excluded if they had a serious physical or mental illness. The sample size of 156 was calculated using the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) \[[@CR11]\]. This guideline advises 5--10 participants per item of the questionnaire. We slightly increased the sample size to account for incorrect filling of questionnaires.

Questionnaires {#Sec4}
--------------

The Multimorbidity Treatment Burden Questionnaire (MTBQ) has 10 questions and three additional optional questions (questions which did not apply in a UK context but may apply to other populations). For the C-MTBQ, -these three additional questions were included. For each question, answers are ranked using a 5-point Likert scale, ranging from 0 (does not apply or not difficult),1 (a little difficult), 2(quite difficult), 3(very difficult) and 4 (extremely difficult). The global MTBQ score is calculated as the mean score, multiplied by 25, giving a score of 0 to 100. Global treatment burden scores can be categorized as: no-treatment burden (0), low treatment burden (\< 10), medium treatment burden (10--22), high treatment burden (≥22).

The Treatment Burden Questionnaire (TBQ) was originally developed by Tran \[[@CR12]\] and measures the perceived treatment burden of patients with long term conditions. It has been translated into many countries \[[@CR12], [@CR13]\]. It includes 15 questions and four dimensions: medication(1A \~ 1D), seeing doctors and subsequent visit (2A \~ 2E), medical related and lifestyle(3A \~ 3E) and health problem(4A), A 10-point Likert scale is used, ranging from 0 (no burden) to 10 (high burden). The global score of the TBQ is calculated as the sum of the answers to each item and ranges from 0 to 150, with higher scores indicating a higher level of treatment burden.

Translation process {#Sec5}
-------------------

Researchers followed the Brislin model to translate the MTBQ into Chinese \[[@CR14]\]. Step 1: The MTBQ was independently translated into Chinese by two researchers with Chinese linguistic backgrounds(T1, T2). T1 has a Master's degree and is medically trained and T2 has a postgraduate degree in English with no medical training. Step 2: A third researcher, who has a Master's degree in nursing and 6 years of IELTS training experience, reviewed and synthesized the translated versions created by T1 and T2, referring to the original English version. Step 3: two bilingual translators(One is a Master's degree student in English, the other is a Nursing PhD)back-translated the synthesized version into English to highlight conceptual errors in the translations. Step 4: All translators and team members compared the original MTBQ and the two back-translation versions to form a comprehensive back-translation version to confirm accuracy \[[@CR15]\]. The comprehensive back-translation was reviewed by the original MTBQ author(PD), and minor revisions were made until the comprehensive back-translation version and the original questionnaire had a semantic consistency rate of over 90%.

Cross-cultural adaptation {#Sec6}
-------------------------

Six experts conducted the cross-cultural adaptation: two general medical doctors; two hospital nurses who specialize in long-term conditions; a nurse who specializes in care of the elderly and the director of the care of the elderly hospital department.

They first evaluated the Chinese version of MTBQ in terms of accuracy, simplicity of the text, grammar, use of proper terms and syntax. The cultural relevance (language clarity, language habits, cultural background conformity and content relevance) and content validity were evaluated using a 4-point rating scale ranging from 1 (not relevant) to 4 (very relevant) to ensure the cultural applicability and content equivalence of the questionnaire \[[@CR16]\]. The content validity index (CVI) (the proportion of questions rated by experts as either 3 or 4) was calculated.

Piloting {#Sec7}
--------

The final version of the MTBQ was piloted in 30 elderly patients who met the inclusion criteria. We found that they could understand the items easily and that they required an average of 5 minutes to finish the questionnaire.

Questionnaire administration {#Sec8}
----------------------------

The questionnaires were administered face-to-face by three post-graduate students who were trained by the research team. Participants were identified by nursing staff working on the hospital wards. Data from the patient's hospital records was collected with written consent.

Statistical analysis {#Sec9}
--------------------

Data were analysed using SPSS version 21.0. Descriptive statistics were generated to describe the participants' characteristics. The distribution of responses for each question, proportion of missing data, proportion of 'does not apply' responses and floor and ceiling effects were examined. An exploratory factor analysis (EFA) was conducted to evaluate the dimensionality of the questionnaire \[[@CR17]\], and the number of extracted factors was determined using the principal-component analysis (PCA) and varimax rotation. Factor loadings (λ) \> 0.40 or \< − 0.40 were considered acceptable \[[@CR18]\].

To assess internal consistency reliability, we examined the inter-item correlation matrix and calculated Cronbach's alpha (0.7--0.95 was deemed acceptable) \[[@CR11], [@CR19]\]. Test-retest reliability was assessed by comparing the total C-MTBQ scores in a subset of patients who completed the questionnaire on both day 0 and day 14. The intraclass correlation coefficient (ICC) was calculated and interpreted as follows: excellent (\> 0.8), good (0.61--0.80), moderate (0.41--0.60), fair (0.21--0.40) and poor (≤0.20) \[[@CR20]\]. To assess criterion validity, we examined the relationships between C-MTBQ and the Chinese version of the TBQ.

We examined the distribution of scores for each question. Ceiling and floor effects were considered to be present if more than 15% of respondents achieved the lowest (0) or highest (4) score, respectively.

Ethical approval {#Sec10}
----------------

The study was approved by the ethics committee of People's Hospital of Zhengzhou. Written consent was taken for all the participants.

Results {#Sec11}
=======

Translation and cultural adaptation {#Sec12}
-----------------------------------

"Health professionals" (questions 6, 7, and 8) was replaced by the traditional Chinese word for "medical staff" as the experts felt this was, the more commonly used expression. During interviews with participants, for the "appointments" in questions 6 and 8, the participants reports that there was no need to make an appointment to see a doctor in hospital mostly, so we removed the word "appointments". The item CVIs ranged from 0.83 \~ 1.00, while the scale CVI was 0.89, indicating good content validity of the C-MTBQ.

Description of sample {#Sec13}
---------------------

One hundred and fifty-six participants completed the study. There characteristics are shown in Table [1](#Tab1){ref-type="table"}. The average age was 73.5 years (60--99 years) with slightly more males (54.5%). Less than a fifth had a college education. Two thirds of patients had three or more long-term conditions. Table 1Sample characteristics (*n* = 156)CharacteristicsN%Gender Male8554.5 Female7145.5Age(years) 60 \~ 706340.4 70 \~ 804629.5 80 \~ 904025.6  ≥ 9074.5Marital status married13284.6 Single/divorced/widowed2415.4Education Level No formal/Primary education3925.0 Secondary education9158.3 Tertiary education2616.7Household income per month(Yuan)  \< 10003019.2 1000 \~ 30004126.3 3000 \~ 50005334.0  ≥ 50003220.5Living Status Living alone2214.1 Living with others13485.9Health insurance Town medical insurance11573.7 New Rural Cooperative2717.3 Public medical care138.3 Others10.6Long-term conditions Cardiovascular Disease14995.5 Stroke/Transient Ichaemic attack10466.7 Diabetes8151.9 Chronic kidney disease3421.8 Chronic obstructive culnar disease or asthma2012.8 Atrial fibrillation2314.7 Depression74.5 Joint disease3119.9 Heart failure149.0Number of chronic diseases 25334.0 37246.2 41912.2  ≥ 5127.7

The descriptive statistics of the C-MTBQ {#Sec14}
----------------------------------------

The proportion of missing data for each question was 0% (see Table [2](#Tab2){ref-type="table"}). For the optional question about "Getting help from community health services (eg, physical therapy, health services provided by community nurses, etc.)", 64% of patients responded "does not apply". As this was greater than 40%, this question was removed from the questionnaire. High floor effects (the proportion of participants who responded 'not difficult' or 'does not apply') were found for all questions. The range of skewness was between 0.453 and 2.093, and the range of kurtosis was between 0.040 and 3.721, indicating that the items of the C-MTBQ were non-normally distributed. The global C-MTBQ scores were skewed and varied from 2 to 60. None of participants had a global C-MTBQ score of 0, and no treatment burden(0), low treatment burden(\< 10), medium treatment burden(10--22) and high treatment burden (≥22) accounted for 0, 14.7, 39.7 and 45.5%, respectively. The median C-MTBQ total score was 20.8 (interquartile range 12.5--29.2). Table 2Response to the C-MTBQ (*n* = 156)Item, Description of itemNNot difficult\
n(n/N%)A little difficult n(n/N%)Quite difficult\
n(n/N%)Very difficult\
n(n/N%)Extremely difficult\
n(n/N%)Dose not applyn(n/N%)1. Taking lots of medications15673(47)60(39)20(13)2(1)1(1)0(0)2. Remembering how and when to take medication15690(58)44(28)19(12)1(1)0(0)2(1)3. paying for medications and treatment15659(38)31(20)20(13)32(21)14(9)0(0)4. take medicine regularly15645(29)55(35)30(19)4(3)1(1)21(14)5.Monitoring your medical conditions (e.g. checking your blood pressure or blood sugar, monitoring your symptoms etc.)15634(22)46(30)29(19)20(13)2(1)25(16)6. To see a doctor about a health issue15659(38)62(40)27(17)4(3)0(0)4(3)7. Go to see different doctors15639(25)75(48)24(15)3(2)0(0)15(10)8. getting time off work, arranging transport etc. to see doctors15664(41)44(28)16(10)2(1)0(0)30(19)9. Getting health care in the evenings and at weekends15698(63)26(17)4(3)0(0)0(0)28(18)10. Getting help from community services (e.g. physiotherapy, district nurses etc.)15623(15)15(10)11(7)6(4)1(1)100(64)11.Obtaining clear and up-to-date information about your condition15629(19)65(42)32(21)26(17)4(3)0(0)12.Making recommended lifestyle changes (e.g. diet and exercise etc.)15630(19)65(42)45(29)10(6)0(0)6(4)13.Must rely on support from family members and friends15611(7)72(46)25(16)0(0)1(1)47(30)

Factor analysis {#Sec15}
---------------

The Kaiser-Meyer-Olkin (KMO) measure of sampling adequacy(0.776) and the Bartlett test of sphericity (*p* \< 0.001) showed that factor analysis of the data was appropriate \[[@CR21], [@CR22]\]. The scree plot is shown in Fig. [1](#Fig1){ref-type="fig"}. Three common factors were obtained, which explained the total variance of 54%, loadings of all items ranged from 0.505 to 0.816. The eigenvalue of the three factors were -2.494, 2.022 and 1.960, respectively. The original English MTBQ had only one dimension. According to the content characteristics, factor 1 (1,2,6,7) was named as the medication and treatment dimension (4 items); factor 2 (3,4,8,9,13) was named as the medical related dimension (5 items), and factor 3(5、11、12) was named as the daily self-health management dimension. The three dimensions represented are shown in Table [3](#Tab3){ref-type="table"}. Fig. 1Scree plot of C-MTBQTable 3Factor analysis, internal consistency of C-MTBQItemmedication and treatmentmedical relateddaily self-health managementCronbach's Alpha if Item DeletedCorrected item-total correlation1**0.816**0.0810.0630.7360.5272.**0.798**−0.0890.2540.7350.5366**0.641**0.2960.3410.7150.6957.**0.680**0.314−0.070.7390.5013.−0.226**0.708**0.1190.7780.4554.0.312**0.561**0.4150.7130.70180.202**0.619**0.0680.7380.51490.240**0.568**−0.0470.7480.403130.086**0.505**0.4530.7310.57350.247−0.068**0.586**0.7510.485110.0330.171**0.716**0.7360.564120.0240.106**0.718**0.7410.499Eigenvalue**2.4942.0221.960**% of Variance Explained (rotation solution)**20.78016.85016.337**Cumulative % of Variance Explained (rotation solution)**20.78037.62953.966**A value of 0.40 or greater for the factor loadings was regarded as acceptable.

Reliability {#Sec16}
-----------

The Cronbach's alpha and the corrected item-total correlations of all 12 questions are shown in Table [3](#Tab3){ref-type="table"}. Item-total correlations ranged from 0.403 (item 9) to 0.701 (item 4), and all items met the recommended minimum of 0.20. Removing any item of the C-MTBQ didn't result in severely changing in the value of Cronbach's alpha. The internal consistency coefficient for the total score of the C-MTBQ were showed with a Cronbach's alpha of 0.755. Thirty of the 156 participants were randomly selected to evaluate the test-retest reliability. The mean scores of the first and second measurements were 19.79 (interquartile range 19.79--29.17) and 21.00 (interquartile range 14.75--25.50), respectively. The test-retest reliability was satisfactory with an ICC of 0.944.

Criterion validity {#Sec17}
------------------

Correlations of C-MTBQ with TBQ and TBQ subscales scores are displayed in Table [4](#Tab4){ref-type="table"}. The results suggested moderate to high correlations of C-MTBQ with TBQ score (r = 0.875) and TBQ subscales scores (r: 0.495 \~ 0.740). Table 4Correlation (r) for the C-TBQ and C-TBQ subscales with the C-MTBQ of the Constant-Murley scoreCriterionsC-TBQ -medicationC-TBQ-seeing doctors and subsequent visitC-TBQ-medical related and lifestyleC-TBQ-health problemTBQC-MTBQ0.7260.5890.7400.4950.875*C-MTBQ* The Chinese version of the Multimorbidity Treatment Burden Questionnaire, *C-TBQ* The Chinese version of the Treatment Burden Questionnaire

Discussion {#Sec18}
==========

In this study we have translated, culturally adapted and validated a 12-item questionnaire, named the Chinese Multimorbidity Treatment Burden Questionnaire (C-MTBQ). We followed the standard forward-backward translation process and examined the psychometric properties of the C-MTBQ in hospitalized Chinese elderly patients with multimorbidity. The C-MTBQ demonstrated good content validity, internal consistency reliability, test-retest reliability and criterion validity. A three-factor structure was found, which is different to the one factor structure of the original MTBQ.

The question 10 "Getting help from community health services (eg, physical therapy, health services provided by community nurses, etc.)" was deleted, because 64% of patients responded "does not apply". This may be due to differences between community health services in the UK and China, with primary care being less well developed in China and patients preferring to seek treatment from hospitals \[[@CR23], [@CR24]\].

The median C-MTBQ total score was 20.8, and the median C-TBQ score was 16. It is difficult to draw comparisons since the global score for each questionnaire is calculated differently \[[@CR25]\]. All the questions have high floor effects, which were similar to the C-TBQ. This may be in part due to the sample frame as all the participants were elderly, unemployed or retired and hence they had time to remember how and when to take medications and to monitor their medical conditions. Also they did not need to take time off work to see doctors. Further studies involving younger patient populations, particularly those with busy work patterns may reveal a different pattern of scores. A lack of a ceiling effect indicates that the C-MTBQ may be better for monitoring deterioration in treatment burden.

According to the results of factor analysis, all of the 12 questions of the C-MTBQ were grouped into three factors, and factor loadings reached the criteria of 0.40. By comparison, the original MTBQ was unidimensional. This may have potential implications for instrument scoring. There are several explanations for this. Firstly, item 10 was deleted from the C-MTBQ. Secondly, the sample size for the C-MTBQ was small compared to the original English questionnaire which was validated in 1500 patients with multimorbidity \[[@CR9], [@CR26]\]. Thirdly, the participants of the original questionnaire were ≥ 18 years, participants of this research were aged ≥60 years. Lastly, there are important cultural differences between the UK and China and this is likely to impact on perceived treatment burden \[[@CR27]\]. In terms of criterion validity, the C-MTBQ correlated well with TBQ score (r = 0.875), which indicated that the C-MTBQ had a good criterion validity.

For the Internal consistency, the results showed a little lower internal consistency with a Cronbach's alpha of 0.755 than the value validated in original MTBQ(0.83) \[[@CR9]\], indicating good reliability. The test-retest reliability coefficient of our questionnaire was 0.944, which showed that the questionnaire had time consistency.

The MTBQ uses simple language and is suitable for elderly people to complete. The average time to complete the questionnaire was about 5 minutes, which was shorter than C-TBQ. The questionnaire has clear and detailed instructions. For investigators using the questionnaire, there are clear instructions on calculating, reporting and interpreting global MTBQ scores. However, there are also limitations. Firstly, the sample size was relatively small. Secondly, convenience sampling method were used and the samples were all from only one hospital in Zhengzhou, China, which may make it difficult to generalize the findings to a wider population in China. Moreover, this research only focused on older adults and the results may not be generalizable to younger people. Further research is needed to validate the C-MTBQ amongst younger people living in other provinces of China.

Conclusion {#Sec19}
==========

The Chinese version of multimorbidity treatment burden questionnaire (C-MTBQ) had good reliability and validity. It can be used as a patient-reported outcome measure to assess the treatment burden in Chinese-speaking elderly patients with multimorbidity in hospital.
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